Adjuvant Chemotherapy In Gastric Cancer Quito-Ecuador

Thumbnail Image
Files
gjra2019v8n9p55.pdf (477.18 KB)
Date
2019-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
World Wide Journals
Abstract
OBJECTIVE:To determine the overall survival time in patients treated with adjuvant chemoradiotherapy.METHODS:Retrospectivestudyofpatientswithadiagnosisofgastricadenocarcinomaor gastroesophageal junction who received adjuvant chemoradiotherapy treatment during the years 2011 to 2015.RESULTS:We analized 197 subjects of which 115 were men (58.4%) and 82 women (41.6%) were included in the analysis; between the ages of 18 and 89 years old, distributed in clinical stages IB to IIIC, showing a general average survival of 51.5 months with a Log Rank of 2.98; 95% CI (45.7 - 57.4) with a general survival of up to 90 months.CONCLUSION:The study showed a greater overall survival than the data reported in the Intergroup 0116 and ARTIST study.
Description
Keywords
Gastric Cancer, Chemotherapy, Adjuvant, Quito, Ecuador
Citation
Galarza Ivonne Bravo, Erazo Christian Aguilar, Cervantes Ana Calderon, Vazquez Mabel Sisalima, Moreno Nelson Urbina, Guachamin Priscila Yepez, Gavilanez Alex Montes De Oca, Herrera Maria Herrera. Adjuvant Chemotherapy In Gastric Cancer Quito-Ecuador. Global Journal For Research Analysis. 2019 Sep; 8(9): 55-57
URI
https://imsear.searo.who.int/handle/123456789/184919
Collections
Global Journal For Research Analysis